CVSI DD: Pending news,Golden Cross on Friday http://stockcharts.com/h-sc/ui?s=CVSI (most bullish technical sign, MA50 Crossed MA200). I spent several hours last week and did a comparison between all recent pot/medical runners stocks around and I can tell you that this stock has one of the best balance sheet, very impressive grow rate and also has several times revenues than most. Market cap is still tiny compare to others w/much worse balance sheet and much lower equity. also pending news anytime per past month update and several upcoming Milestones ahead.
almost no one talking about her via social media, the meaning is the impressive volume doesn't comes from day-traders, another big plus.
Not only CVSI has most solid and rare balance sheet w/ Assets/Liabilities Ratio of 5.5 but also no one even close to its revenues and grow rate. CVSI still a micro cap Co. but not for long imo. those runners( 400%-1500% this month)has less than 200k in assets, up to 10 times Liabilities and 40 times Deficit or a Negative Assets/ Liabilities Ratio. My conclusion is that CVSI is a ground floor opp. With so tiny cap, solid balance sheet and impressive grow rate, I won't be surprised to see a several times PPS this the near future and cap still will be reasonable imo.
Pending news and pending Patent per September 19, 2016 updates: "Our products are distributed nationally in health food stores, in health care providers’ offices and online, and we will continue expanding existing and new sales channels through the education and marketing efforts in partnership with broker relationships and physician educators. In the coming weeks, we will be announcing other upcoming product line extensions and new launches that include a new vape brand, a point-of-sale specialty beverage and a body care line, which will further contribute to our growth strategy.
The CT order filed recently makes it more interesting.
500% grow rate/a year: our top-selling brand, has more than 30 SKUs, including capsules, sprays, oils and topicals, and is sold in over 700 retail stores. This is a significant increase from the 120 locations we had a year ago and is a testament to the value of our brand, which continues to provide a strong platform for growth and value creation.
CVSI CEO: "this is a great time to be involved with CV Sciences as we move forward in this exciting time ahead".
"The Company has sufficient cash reserves and access to capital to meet its working capital requirements. Stockholders’ equity amounted to approximately $21.8 million as of June 30, 2016".
Not only The Company just Initiates Preclinical Drug Development Program to Address $5.3 Billion Market Opportunity in Cessation of Smokeless Tobacco, but also CV Sciences funds the work of the University of Kentucky's first graduate student focused entirely on hemp and cannabinoid research, who is studying various methods to increase cannabinoid production. The company plans to continue to expand research efforts with universities and Kentucky farmers through the remaining years of the pilot project. CV Sciences just got a strong position in the industry, with continued cooperation from the Kentucky Department of Agriculture, allowed Kentucky farmers and academic institutions to be some of the first in the country to have seed in hand and in the ground.
CVSI is a real Company, real revenues, real suppliers , real distribution network, impressive grow rare and has real future, while market cap still a joke.
My recent comparison relating CANN,OWCP,CBIS and others.
News 
Market Data 
Discover 
